ARFIP2

ARFIP2 (POR1/arfaptin 2) is a membrane-associated effector that couples small GTPase signaling to actin cytoskeletal rearrangement and membrane curvature sensing at the cell periphery (PMID:9312003, PMID:25539497). It binds GTP-loaded ARF1, ARF5, and ARF6 as a downstream effector, while engaging Rac1 in the opposite nucleotide state by binding GDP-Rac1 rather than GTP-Rac1 (PMID:9312003, PMID:11478794). This dual specificity underlies a curvature-dependent switch: on highly curved membranes ARFIP2 preferentially partitions to the bilayer, releasing Rac1 for activation, whereas on low-curvature membranes it sequesters inactive Rac1 and competitively blocks its activation, a behavior that also modulates osteoblast differentiation (PMID:25539497). In the context of lysosomal damage and intracellular bacterial infection, ARFIP2 acts as a component of ATG9A vesicles, binding and sequestering PI4P on damaged lysosomes to balance OSBPL-dependent lipid transfer and recruiting the AP-3 adaptor complex to drive ATG9A vesicle retrieval and PI4K2A delivery, thereby supporting lysosomal repair and homeostasis (PMID:40460835).

1. 1997 Medium

   Established ARFIP2/POR1 as a regulatory effector linking ARF6 to peripheral actin polymerization, answering whether ARF6 acts on the cytoskeleton through an intermediary protein.

   Evidence GTP-dependent direct interaction assay plus co-expression of POR1 deletion mutants with actin polymerization readout in cells

   PMID:9312003

   Open questions at the time

   • Did not define the structural basis of GTP-dependent binding
   • Did not resolve whether ARF1/ARF5 also engage POR1
2. 2001 Medium

   Defined the nucleotide-state specificity of ARFIP2, showing it is an effector of GTP-ARF1/5/6 yet binds Rac1 only in the GDP-bound state, reframing its relationship to Rac1 signaling.

   Evidence Yeast two-hybrid and GST pull-down with active, wild-type, and dominant-negative ARFs and Rac1

   PMID:11478794

   Open questions at the time

   • Functional consequence of GDP-Rac1 binding not yet established
   • No structural mapping of the distinct ARF versus Rac1 interfaces
3. 2015 Medium

   Connected ARFIP2's nucleotide-opposite binding to a membrane-curvature-sensing mechanism that gates Rac1 activation and influences osteoblast differentiation.

   Evidence siRNA knockdown with Rac1/Arf1 activation pull-down assays and ALP activity on defined-diameter nanofibers

   PMID:25539497

   Open questions at the time

   • Curvature thresholds defined on synthetic nanofibers, not native membranes
   • Molecular determinants of the curvature switch not dissected
4. 2025 High

   Placed ARFIP2 in lysosomal repair as an ATG9A-vesicle component that sequesters PI4P and recruits AP-3, answering how PI4P levels and PI4K2A delivery are balanced on damaged lysosomes.

   Evidence Lysosomal damage models (sterile and bacterial), vesicle fractionation, PI4P binding and AP-3 recruitment assays, and loss-of-function with live imaging (peer-reviewed; preprint at idx 3)

   PMID:40460835

   Open questions at the time

   • Structural basis of PI4P sequestration not resolved
   • Relationship between the ARF/Rac1 cytoskeletal role and the lysosomal role unclear
   • Direct interaction of ARFIP2 with AP-3 subunits not mapped

• How ARFIP2's GTPase-effector and curvature-sensing activities mechanistically integrate with its ATG9A/PI4P lysosomal repair function remains unresolved.
• No unified structural model across functions
• Tissue/context determinants of which role dominates unknown